针刀治疗膝骨关节炎患者:随机对照试验研究方案
本研究为单盲、假针刀对照的随机对照试验方案,计划纳入136例有症状的膝骨关节炎患者,比较针刀与假针刀(均每周1次共2次,外用吲哚美辛乳膏)的疗效。主要结局为WOMAC指数,次要结局包括VAS评分、足底压力分布、X线、肌骨超声、最大膝围、关节活动度和生活质量,随访至6个月。
要点
- 针刀组与假针刀组各接受2次治疗(每周1次,共2周),所有患者外用吲哚美辛乳膏。
- 主要结局为WOMAC指数,在基线、治疗结束后1周及3、6个月随访时测量。
- 本研究为单盲、假针刀对照设计,结局评估者设盲。
核心结论
- 该研究旨在验证针刀治疗膝骨关节炎的疗效,为针刀提供高质量随机对照证据。
研究设计与样本
- 单盲、假针刀对照的随机对照试验方案,计划纳入136例膝骨关节炎患者。
- 受试者来自广州中医药大学第一附属医院,按区组随机方案分配至针刀组或假针刀组。
关键数值与推荐
- 针刀组接受2次针刀治疗,为期2周(每周1次);假针刀组接受2次假刺激,为期2周(每周1次)。
- 所有患者外用吲哚美辛乳膏。
- 主要结局为WOMAC指数;次要结局包括VAS评分、足底压力分布测试、X线检查、肌骨超声、最大膝围、关节活动度和生活质量。
- 测量时间点为基线、治疗结束后1周以及3个月和6个月随访。
临床怎么用
- 若研究证实有效,针刀可作为膝骨关节炎的非药物疗法选择之一。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Symptomatic knee osteoarthritis (KOA) is common in China. Pharmacological therapy is not the first recommendation because of its safety issues. Nonpharmacological therapy, such as lifestyle adjustments, weight loss, muscle strengthening, and aerobic exercise programs, is strongly recommended for KOA. However, these approaches may fail due to poor patient compliance. There is a lack of high-quality randomized controlled trials of acupotomy, an effective treatment for KOA. This study was designed to investigate the efficacy of acupotomy in patients with KOA. METHODS: A total of 136 patients will be enrolled at the First Affiliated Hospital of Guangzhou University of Chinese Medicine and assigned to the acupotomy group or sham acupotomy group according to the block randomization scheme. Patients in the acupotomy group will receive 2 sessions of acupotomy for 2 weeks (once a week). Patients in the sham group will receive 2 sessions of sham stimulation for 2 weeks (once a week). All patients will use indomethacin cream externally. The primary outcome will be the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and the secondary outcomes will be the visual analog scale (VAS) score, plantar pressure distribution test result, X-ray examination findings, musculoskeletal ultrasound findings, maximum knee circumference, joint mobility, and quality of life. Measurements will be taken at baseline, 1 week after the end of treatment, and at the 3- and 6-month follow-ups. DISCUSSION: To the best of our knowledge, this will be the first single-blind, sham-controlled study of acupotomy. The outcome assessors will also be blinded. The aim of this work is to demonstrate the efficacy of acupotomy in treating KOA. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2000033047 . Registered on 18 May 2020.
引用
- Xu D, Lee M, Huang C, et al. Effect of acupotomy in knee osteoarthritis patients: study protocol for a randomized controlled trial. Trials. 2021. PMID: 33879221. doi:10.1186/s13063-021-05247-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。